There is no routine screening for ovarian cancer.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Major randomized controlled trials, such as the UKCTOCS, have demonstrated that population screening does not significantly reduce ovarian cancer mortality, and as a result, routine screening is not recommended for the general public.

The analysis

The claim states that there is no routine screening for ovarian cancer. High-quality clinical evidence and major trials (like UKCTOCS) and recent consensus reviews explicitly confirm that population-wide routine screening is not recommended or implemented because it fails to reduce mortality and lacks sufficient test performance. Thus, the claim is supported.

Evidence for · 2

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Recorded source metadata

Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Andy Ryan, Jatinderpal K Kalsi, Naveena Singh, Anne Dawnay, Lesley Fallowfield, Alistair J McGuire, Stuart Campbell, Steven J Skates, Mahesh Parmar, Ian J Jacobs. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. 2025. https://doi.org/10.3310/ckuy6010

The large UKCTOCS randomized controlled trial established that population screening for ovarian cancer does not significantly reduce disease-specific deaths, leading to the conclusion that general population screening cannot be recommended.

Source citation format

See more details

More for · 1

Advances in ovarian cancer screening and early detection: from biomarkers to multivariate index assays.

Recorded source metadata

Salomon C, Razo-Azamar M, Gentry-Maharaj A, Rice GE, Menon U. Advances in ovarian cancer screening and early detection: from biomarkers to multivariate index assays.. 2026. https://doi.org/10.1080/14737159.2025.2608820

Recent clinical literature affirms that existing modalities lack sufficient sensitivity and specificity, and no ovarian cancer screening test is currently approved for routine use.

Source citation format

The paper trail · every fact has a biography

first checked02 Aug 2026

judged → SUPPORTED · 7902 Aug 2026

More receipts

Is it true that Phonological evolution involves regular processes of phoneme elision, vowel nasalization, and tonogenesis?Is it true that Hemangiomas are treatable with medication?Is it true that Research identifies forms of intelligence that diverge from standard IQ measures?

Random receipt →The Trust Wiki →

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt